Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pluristem Therapeutics Inc (NASDAQ:PSTI)

0.8098
Delayed Data
As of Feb 12
 +0.0148 / +1.86%
Today’s Change
0.71
Today|||52-Week Range
3.28
-28.34%
Year-to-Date
No recent news for Pluristem Therapeutics Inc.

Today’s Trading

Previous close0.80
Today’s open0.78
Day’s range0.78 - 0.83
Volume40,083
Average volume (3 months)294,399
Market cap$64.7M
Dividend yield--
Data as of 3:58pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+16.67%
Earnings growth (this year)--
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales467.33
Price/Book1.08

Competitors

 Today’s
change
Today’s
% change
CURNeuralstem Inc-0.00-0.39%
TENXTenax Therapeutics I...+0.02+0.85%
CRMDCorMedix Inc+0.27+16.67%
PIRSPieris Pharmaceutica...+0.01+0.66%
Data as of 4:01pm ET, 02/12/2016

Financials

Next reporting dateFebruary 15, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$379.0K
Annual profit (last year)-$24.7M
Net profit margin-6,511.08%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Zami Aberman
President, CFO, COO &
Secretary
Yaky Yanay
Corporate headquarters
Haifa, Haifa

Forecasts

Partner Offers